After obtaining a master of science in biotechnology, I felt the need to work in a field where I could have a real impact on people. I therefore graduated from a master in Human Resources. After several years working as a Human Resource Manager in the industry, I decided to work in an even more meaningful environment by becoming a midwife, while living in Ireland. I practiced for five years in France and during that time, was involved in various committees which purpose was to improve the overall French health system performance, with a specific focus on newborns and their mother. Empowering mothers, patients, from research to therapy, must be the goal of everybody involved. I recognize myself in the purpose of The Synergist which I feel very lucky indeed to join as a program manager.
The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed in collaboration with The Synergist. Its goal is to bring together initiatives and best practices that integrate the voice of the patient throughout the lifecycle of medicines development, thereby speeding up the creation and implementation of an effective, globally standardized framework. PFMD seeks to have a balanced representation of stakeholders to ensure transparency, inclusiveness, and credibility. Stakeholders include patients and patient organizations across diverse areas of health and industry. We also intend to invite regulators, payers and other professional organizations to the global group to ensure diversity of perspectives.
Our vocation is to be committed to therapeutic progress for the benefit of patients in connection with health professionals, in order to transmit to future generations a world where health is accessible to the greatest number.We put patients first. They are at the heart of each of our activities. We believe that the best way to meet their current and future needs is to work together. All of our considerations, decisions, and actions—from basic research to getting a medicine to market—are governed by this central position of patients.